An attorney who handled a prominent negligence case against a Kentucky compounder advises veterinarians and horse owners to make sure they are acting legally when administering a compounded drug to a horse.
In a 12-month period that has seen drug compounders linked to horse deaths at a training center and integrity issues at the track, the Kentucky Horse Racing Commission is researching ways it could add regulatory oversight.
The U.S. Food and Drug Administration reports the number of Thoroughbreds who died after receiving a compounded drug from Wickliffe Pharmacy in Lexington, Ky. has grown to four, and six others have become ill.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
Scientists are warning horse owners and veterinarians to be cautious about using compounded (private pharmacy-mixed) gastric ulcer medications.
Most Popular Stories
- Catch a Glimpse in Good Order After Nassau Scare
- G. G. Ryder Wins All American in Blanket Finish
- Weekend Hideaway Repeats in Commentator
- Gun Runner Breezes for Stephen Foster
- Connections Plan Breeders' Cup Trip for Top Casablanca
- Fourstar Crook Continues Turf Win Streak
- Danzing Candy Wires Lone Star Handicap
- Rey de Oro wins Japanese Derby
- Cupid Returns From Layoff to Win Gold Cup
- Ashleyluvssugar Wins Second Charles Whittingham